Results 181 to 190 of about 226,631 (261)

Reply to “Aflibercept 8 mg: From Ocular Clearance to Pharmacodynamic Duration”

open access: yes
CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 11, November 2026.
Sébastien Bihorel   +8 more
wiley   +1 more source

A meta-analysis of clinical outcomes in diabetic macular edema. [PDF]

open access: yesAdv Ophthalmol Pract Res
Bobrek CN   +4 more
europepmc   +1 more source

Early high‐dose aflibercept 8 mg clinical outcomes in wet age‐related macular degeneration patients resistant to aflibercept 2 mg or faricimab

open access: yes
Acta Ophthalmologica, Volume 104, Issue 7, Page e885-e887, November 2026.
Pinja Sutinen   +2 more
wiley   +1 more source

Early Intraretinal Fluid Reduction is Linked to Vision Gains in Patients with Diabetic Macular Edema. [PDF]

open access: yesOphthalmol Ther
Wang Y   +12 more
europepmc   +1 more source

Prevalence and Optical Coherence Tomography Biomarker Profile in Diabetic Macular Edema Among Occidental Mexican Patients. [PDF]

open access: yesMedicina (Kaunas)
Arévalo-Simental DE   +10 more
europepmc   +1 more source

Inflammatory Biomarkers in Diabetic Macular Edema. [PDF]

open access: yesJ Clin Med
Campos A   +14 more
europepmc   +1 more source

Hydroxychloroquine‐Associated Photosensitivity: A Case Report With Repeat Phototesting

open access: yes
Photodermatology, Photoimmunology &Photomedicine, Volume 42, Issue 6, November 2026.
John Warner‐Levy   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy